BMCMI
SRDX

Bryn Mawr Capital Management Inc’s Surmodics SRDX Stock Holding History

Bryn Mawr Capital Management Inc’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-42,901
Closed -$779K – 606
2014
Q3 		$779K Buy
42,901
+29,843
+229% +$596K 0.08% 263
2014
Q2 		$280K Sell
13,058
-13,816
-51% -$296K 0.03% 500
2014
Q1 		$607K Buy
+26,874
New +$656K 0.05% 282

Other funds holding SRDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Bryn Mawr Capital Management Inc's SRDX Position: Q4 2014 in Review

Bryn Mawr Capital Management Inc sold out of Surmodics (SRDX) in Q4 2014, closing a stake of 42,901 shares — an estimated $779K sold.

Bryn Mawr Capital Management Inc first reported a position in SRDX in Q1 2014 and held it in 3 quarters. The position peaked at $779K in Q3 2014. 113 funds tracked by Wall St. Rank hold SRDX as of Q4 2014.

  • Bryn Mawr Capital Management Inc reported no remaining Surmodics position as of Q4 2014 after selling out during the quarter.
  • Bryn Mawr Capital Management Inc sold 42,901 Surmodics shares in Q4 2014, an estimated $779K.
  • Bryn Mawr Capital Management Inc first reported a position in Surmodics in Q1 2014 and held it in 3 quarters.
  • Bryn Mawr Capital Management Inc's Surmodics position peaked at $779K in Q3 2014.
  • 113 funds tracked by Wall St. Rank held Surmodics as of Q4 2014.

Based on Bryn Mawr Capital Management Inc's 13F filing for Q4 2014, filed 13 Feb 2015.